logotype
  • Home
  • About Us
  • Events
    • Upcoming Conferences
    • Past Conferences
  • Event Support
  • Careers
  • Contact Us
logotype
  • Home
  • About Us
  • Events
    • Upcoming Conferences
    • Past Conferences
  • Event Support
  • Careers
  • Contact Us
  • Home
  • About Us
  • Events
    • Upcoming Conferences
    • Past Conferences
  • Event Support
  • Careers
  • Contact Us
logotype
logotype
  • Home
  • About Us
  • Events
    • Upcoming Conferences
    • Past Conferences
  • Event Support
  • Careers
  • Contact Us
July 1, 2023
by info@virtueinsight.comNews

Advanco Acquires Vantage Consulting Group

Advanco, established as a global pharmaceutical and life sciences track and trace solutions provider, has announced the acquisition of manufacturing automation specialist Vantage Consulting Group. The company will continue to be called advanco, with an enlarged client portfolio of...
read more
July 1, 2023
by info@virtueinsight.comNews

TraceLink and PharmaLink Partner Up on Simplifying DSCSA Compliance Process

TraceLink, a leading digital network platform company enabling end-to-end product orchestration, has announced a partnership with PharmaLink. TraceLink will provide comprehensive DSCSA capabilities for PharmaLink customers, enabling pharmacy dispensers to meet the regulatory...
read more
July 1, 2023
by info@virtueinsight.comNews

Tourmaline Bio Agrees To Merge With Talaris Therapeutics

  Talaris Therapeutics, Inc and Tourmaline Bio, Inc. , a late-stage clinical biotechnology company developing transformative medicines, announced that the companies have entered into a definitive agreement under which Tourmaline will combine with Talaris in an all-stock...
read more
July 1, 2023
by info@virtueinsight.comNews

Eli Lilly to acquire Massachusetts-based biotech Sigilon Therapeutics for $309M

Eli Lilly and Co. said Thursday it has agreed to buy a small biotech based in Massachusetts Sigilon Therapeutics Inc in a deal worth about $309 million. Since 2018, Lilly and Sigilon have worked together to develop encapsulated cell therapies, including SIG-002, for the treatment of...
read more
logotype

We strive to produce high quality conferences which include the latest topics which are delivered by world class leaders of the industry.

Facebook-fTwitterYoutubeLinkedin-inInstagramPinterest

Quick Links

About us
Contact us
Event Support
Careers
Privacy Policy
Terms & Conditions

Subscribe to our newsletter

    © 2025 Virtue Insight. All rights reserved.